Full-length sequence analysis of subacute sclerosing panencephalitis (SSPE) virus, a mutant of measles virus, isolated from brain tissues of a patient shortly after onset of SSPE

Microbiology and Immunology

Volumn 50, Issue 7, 2006, Pages 525-534

  Hotta, Hak ^a   Nihei, Kenji ^b,c   Abe, Yu Ichi ^b   Kato, Seiichi ^a   Jiang, Da Peng ^a   Nagano Fujii, Motoko ^a   Sada, Kiyonao ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c Yokohama Rise Okanoue Hospital   (Japan)

Author keywords

Measles virus; Mutation; SSPE virus; Subacute sclerosing panencephalitis

Indexed keywords

CYTIDINE; GENOMIC RNA; GLYCINE CLEAVAGE SYSTEM; GUANINE NUCLEOTIDE BINDING PROTEIN; LEUCINE; M PROTEIN; PROLINE; PROTEIN C; PROTEIN F; PROTEIN H; PROTEIN L; UNCLASSIFIED DRUG; URIDINE; VIRUS PROTEIN; VIRUS PROTEIN V;

ARTICLE; BRAIN TISSUE; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CONTROLLED STUDY; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MEASLES VIRUS; MUTATION RATE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POINT MUTATION; PRESCHOOL CHILD; PROTEIN FUNCTION; SEQUENCE ANALYSIS; STOP CODON; SUBACUTE SCLEROSING PANENCEPHALITIS; SYNCYTIUM; VIRUS CHARACTERIZATION; VIRUS GENOME; VIRUS ISOLATION; VIRUS PARTICLE; VIRUS STRAIN;

MEASLES VIRUS;

EID: 33746342112     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2006.tb03822.x     Document Type: Article

References (45)

1. Anlar, B., Aydin, O.F., Guven, A., Sonmez, F.M., Kose, G., and Herguner, O. 2004. Retrospective evaluation of interferon-β treatment in subacute sclerosing panencephalitis. Clin. Ther. 26: 1890-1894.
2. Ayata, M., Hayashi, K., Seto, T., Murata, R., and Ogura, H. 1998. The matrix gene expression of subacute sclerosing panencephalitis (SSPE) virus (Osaka-1 strain): a comparison of two sibling viruses isolated from different lobes of an SSPE brain. Microbiol. Immunol. 42: 773-780.
3. Ayata, M., Hirano, A., and Wong, T.C. 1991. Altered translation of the matrix genes in Niigata and Yamagata neurovirulent measles virus strains. Virology 180: 166-174.
4. Ayata, M., Komase, K., Shingai, M., Matsunaga, I., Katayama, Y., and Ogura, H. 2002. Mutations affecting transcriptional termination in the P gene end of subacute sclerosing panencephalitis viruses. J. Virol. 76: 13062-13068.
5. Bankamp, B., Horikami, S.M., Thompson, P.D., Huber, M., Billeter, M., and Moyer, S.A. 1996. Domains of the measles virus N protein required for binding to P protein and self-assembly. Virology 216: 272-277.
6. Bankamp, B., Wilson, J., Bellini, W.J., and Rota, P.A. 2005. Identification of naturally occurring amino acid variations that affect the ability of the measles virus C protein to regulate genome replication and transcription. Virology 336: 120-129.
7. Caballero, M., Carabana, J., Ortego, J., Fernandez-Munoz, R., and Celma, M.L. 1998. Measles virus fusion protein is palmitoylated on transmembrane- intracytoplasmic cysteine residues which participate in cell fusion. J. Virol. 72: 8198-8204.
8. Cathomen, T., Mrkic, B., Spehner, D., Drillien, R., Naef, R., Pavlovic, J., Aguzzi, A., Billeter, M.A., and Cattaneo, R. 1998. A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J. 17: 3899-3908.
9. Cattaneo, R., Schmid, A., Eschle, D., Baczko, K., ter Meulen, V., and Billeter, M.A. 1988. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55: 255-265.
10. Cattaneo, R., Schmid, A., Spielhofer, P., Kaelin, K., Baczko, K., ter Meulen, V., Pardowitz, J., Flanagan, S., Rima, B.K., Udem, S.A., and Billeter, M.A. 1989. Mutated and hypermutated genes of persistent measles viruses which caused lethal human brain diseases. Virology 173: 415-425.
11. Cevik, B., Holmes, D.E., Vrotsos, E., Feller, J.A., Smallwood, S., and Moyer, S.A. 2004. The phosphoprotein (P) and L binding sites reside in the N-terminus of the L subunit of the measles virus RNA polymerase. Virology 327: 297-306.
12. Devaux, P., and Cattaneo, R. 2004. Measles virus phosphoprotein gene products: conformational flexibility of the P/V protein amino-terminal domain and C protein infectivity factor function. J. Virol. 78: 11632-11640.
13. Duprex, W.P., Collins, F.M., and Rima, B.K. 2002. Modulating the function of the measles virus RNA-dependent RNA polymerase by insertion of green fluorescent protein into the open reading frame. J. Virol. 76: 7322-7328.
14. Enami, M., Sato, T.A., and Sugiura, A. 1989. Matrix protein of cell-associated subacute sclerosing panencephalitis viruses. J. Gen. Virol. 70: 2191-2196.
15. Gascon, G.G., and International Consortium on Subacute Sclerosing Panencephalitis. 2003. Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): international multicenter study. J. Child Neurol. 18: 819-827.
16. Griffin, D.E. 2001. Measles virus, p. 1401-1441. In Knipe, D.M., and Howley, P.M. (eds), Fields virology, 4th ed, Lippincott Williams & Wilkins Co., Philadelphia.
17. Hirano, A., Ayata, M., Wang, A.H., and Wong, T.C. 1993. Functional analysis of matrix proteins expressed from cloned genes of measles virus variants that cause subacute sclerosing panencephalitis reveals a common defect in nucleocapsid binding. J. Virol. 67: 1848-1853.
18. Hirano, A., Wang, A.H., Gombart, A.F., and Wong, T.C. 1992. The matrix proteins of neurovirulent subacute sclerosing panencephalitis virus and its acute measles virus progenitor are functionally different. Proc. Natl. Acad. Sci. U.S.A. 89: 8745-8749.
19. Itoh, M., Okuno, Y., and Hotta, H. 2002. Comparative analysis of titers of antibody against measles virus in sera of vaccinated and naturally infected Japanese individuals of different age groups. J. Clin. Microbiol. 40: 1733-1738.
20. Jin, L., Beard, S., Hunjan, R., Brown, D.W., and Miller, E. 2002. Characterization of measles virus strains causing SSPE: a study of 11 cases. J. Neurovirol. 8: 335-344.
21. Karlin, D., Longhi, S., and Canard, B. 2002. Substitution of two residues in the measles virus nucleoprotein results in an impaired self-association. Virology 302: 420-432.
22. Katayama, Y., Shibahara, K., Kohama, T., Homma, M., and Hotta, H. 1997. Molecular epidemiology and changing distribution of genotypes of measles virus field strains in Japan. J. Clin. Microbiol. 35: 2651-2653.
23. Kobune, F., Sakata, H., and Sugiura, A. 1990. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J. Virol. 64: 700-705.
24. Komase, K., Haga, T., Yoshikawa, Y., Sato, T.A., and Yamanouchi, K. 1990. Molecular analysis of structural protein genes of the Yamagata-1 strain of defective subacute sclerosing panencephalitis virus. IV. Nucleotide sequence of the fusion gene. Virus Genes 4: 173-181.
25. Komase, K., Haga, T., Yoshikawa, Y., and Yamanouchi, K. 1992. Complete nucleotide sequence of the phosphoprotein of the Yamagata-1 strain of a defective subacute sclerosing panencephalitis (SSPE) virus. Biochim. Biophys. Acta 1129, 342-344.
26. Komase, K., Rima, B.K., Pardowitz, I., Kunz, C., Billeter, M.A., ter Meulen, V., and Baczko, K. 1995. A comparison of nucleotide sequences of measles virus L genes derived from wild-type viruses and SSPE brain tissues. Virology 208: 795-799.
27. Lamb, R.A., and Kolakofsky, D. 2001. Paramyxoviridae: the viruses and their replication, p. 1305-1340. In Knipe, D.M., and Howley, P.M. (eds), Fields virology, 4th ed, Lippincott Williams & Wilkins Co., Philadelphia.
28. Lusida, M.I., Surayah, Sakugawa, H., Nagano-Fujii, M., Soetjipto, Mulyanto, Handajani, R., Boediwarsono, Setiawan, P.B., Nidom, C.A., Ohgimoto, S., and Hotta, H. 2003. Genotype and subtype analyses of hepatitis B virus (HBV) and possible co-infection of HBV and hepatitis C virus (HCV) or hepatitis D virus (HDV) in blood donors, patients with chronic liver disease and patients on hemodialysis in Surabaya, Indonesia. Microbiol. Immunol. 47: 969-975.
29. Moll, M., Klenk, H.-D., Herrler, G., and Maisner, A. 2001. A single amino acid change in the cytoplasmic domains of measles virus glycoproteins H and F alters targeting, endocytosis, and cell fusion in polarized Madin-Darby canine kidney cells. J. Biol. Chem. 276: 17887-17894.
30. Naim, H.Y., Ehler, E., and Billeter, M.A. 2000. Measles virus matrix protein specifies apical virus release and glycoprotein sorting in epithelial cells. EMBO J. 19: 3576-3585.
31. Ning, X., Ayata, M., Kimura, M., Komase, K., Furukawa, K., Seto, T., Ito, N., Shingai, M., Matsunaga, I., Yamano, T., and Ogura, H. 2002. Alterations and diversity in the cytoplasmic tail of the fusion protein of subacute sclerosing panencephalitis virus strains isolated in Osaka, Japan. Virus Res. 86: 123-131.
32. Okuno, Y., Nakao, T., Ishida, N., Konno, T., Mizutani, H., Fukuyama, Y., Sato, T., Isomura, S., Ueda, S., and Kitamura, I. 1989. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan. Int. J. Epidemiol. 18: 684-689.
33. Ono, N., Tatsuo, H., Hidaka, Y., Aoki, T., Minagawa, H., and Yanagi, Y. 2001. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J. Virol. 75: 4399-4401.
34. Page, R.D. 1996. TreeView: an application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 12: 357-358.
35. Palosaari, H., Parisien, J.P., Rodriguez, J.J., Ulane, C.M., and Horvath, C.M. 2003. STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J. Virol. 77: 7635-7644.
36. Patterson, J.B., Cornu, T.I., Redwine, J., Dales, S., Lewicki, H., Holz, A., Thomas, D., Billeter, M.A., and Oldstone, M.B. 2001. Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease. Virology 291: 215-225.
37. Plemper, R.K., Hammond, A.L., and Cattaneo, R. 2000. Characterization of a region of the measles virus hemagglutinin sufficient for its dimerization. J. Virol. 74: 6485-6493.
38. Rima, B.K., and Duprex, W.P. 2005. Molecular mechanisms of measles virus persistence. Virus Res. 111: 132-147.
39. Shaffer, J.A., Bellini, W.J., and Rota, P.A. 2003. The C protein of measles virus inhibits the type I interferon response. Virology 315: 389-397.
40. Shibahara, K., Hotta, H., Katayama, Y., and Homma, M. 1994. Increased binding activity of measles virus to monkey red blood cells after long-term passage in Vero cell cultures. J. Gen. Virol. 75: 3511-3516.
41. Tahara, M., Takeda, M., and Yanagi, Y. 2005. Contributions of matrix and large protein genes of the measles virus Edmonston strain to growth in cultured cells as revealed by recombinant viruses. J. Virol. 79: 15218-15225.
42. Takeda, M., Ohno, S., Seki, F., Nakatsu, Y., Tahara, M., and Yanagi, Y. 2005. Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity. J. Virol. 79: 14346-14354.
43. Takeuchi, K., Kadota, S.I., Takeda, M., Miyajima, N., and Nagata, K. 2003. Measles virus V protein blocks interferon (IFN)-α/β but not IFN-γ signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS Lett. 545: 177-182.
44. von Messling, V., and Cattaneo, R. 2003. N-linked glycans with similar location in the fusion protein head modulate paramyxovirus fusion. J. Virol. 77: 10202-10212.
45. Wong, T.C., Ayata, M., Ueda, S., and Hirano, A. 1991. Role of biased hypermutation in evolution of subacute sclerosing panencephalitis virus from progenitor acute measles virus. J. Virol. 65: 2191-2199.